Westmead Institute for Cancer Research, University of Sydney, Darcy Road (P.O. Box 412), Westmead, New South Wales 2145, Australia.
J Biol Chem. 2012 Mar 2;287(10):7701-16. doi: 10.1074/jbc.M111.327296. Epub 2012 Jan 18.
BRCA1 is a DNA damage response protein and functions in the nucleus to stimulate DNA repair and at the centrosome to inhibit centrosome overduplication in response to DNA damage. The loss or mutation of BRCA1 causes centrosome amplification and abnormal mitotic spindle assembly in breast cancer cells. The BRCA1-BARD1 heterodimer binds and ubiquitinates γ-tubulin to inhibit centrosome amplification and promote microtubule nucleation; however regulation of BRCA1 targeting and function at the centrosome is poorly understood. Here we show that both N and C termini of BRCA1 are required for its centrosomal localization and that BRCA1 moves to the centrosome independently of BARD1 and γ-tubulin. Mutations in the C-terminal phosphoprotein-binding BRCT domain of BRCA1 prevented localization to centrosomes. Photobleaching experiments identified dynamic (60%) and immobilized (40%) pools of ectopic BRCA1 at the centrosome, and these are regulated by the nuclear export receptor CRM1 (chromosome region maintenance 1) and BARD1. CRM1 mediates nuclear export of BRCA1, and mutation of the export sequence blocked BRCA1 regulation of centrosome amplification in irradiated cells. CRM1 binds to undimerized BRCA1 and is displaced by BARD1. Photobleaching assays implicate CRM1 in driving undimerized BRCA1 to the centrosome and revealed that when BRCA1 subsequently binds to BARD1, it is less well retained at centrosomes, suggesting a mechanism to accelerate BRCA1 release after formation of the active heterodimer. Moreover, Aurora A binding and phosphorylation of BRCA1 enhanced its centrosomal retention and regulation of centrosome amplification. Thus, CRM1, BARD1 and Aurora A promote the targeting and function of BRCA1 at centrosomes.
BRCA1 是一种 DNA 损伤反应蛋白,在核内发挥作用,刺激 DNA 修复,在中心体发挥作用,抑制 DNA 损伤后的中心体过度复制。BRCA1 的缺失或突变导致乳腺癌细胞中心体扩增和有丝分裂纺锤体异常组装。BRCA1-BARD1 异二聚体结合并泛素化 γ-微管蛋白,抑制中心体扩增并促进微管核形成;然而,BRCA1 在中心体的靶向和功能调节仍知之甚少。在这里,我们表明 BRCA1 的 N 和 C 末端都需要其在中心体的定位,并且 BRCA1 独立于 BARD1 和 γ-微管蛋白向中心体移动。BRCA1 的 C 末端磷酸蛋白结合 BRCT 结构域中的突变阻止了其向中心体的定位。光漂白实验鉴定了中心体上异位 BRCA1 的动态(60%)和固定(40%)池,这些受核输出受体 CRM1(染色体区域维持 1)和 BARD1 的调节。CRM1 介导 BRCA1 的核输出,出口序列的突变阻止了 BRCA1 在照射细胞中对中心体扩增的调节。CRM1 与未二聚化的 BRCA1 结合,并被 BARD1 取代。光漂白试验表明 CRM1 驱动未二聚化的 BRCA1 向中心体,并揭示了当 BRCA1 随后与 BARD1 结合时,它在中心体上的保留较差,这表明了在形成活性异二聚体后加速 BRCA1 释放的一种机制。此外,Aurora A 结合和 BRCA1 的磷酸化增强了其在中心体的保留和对中心体扩增的调节。因此,CRM1、BARD1 和 Aurora A 促进了 BRCA1 在中心体的靶向和功能。